Our blog has been inundated in the past couple of months with posts highlighting how researchers have used our human primary cells. However, it is not just primary cells. Neuromics also offers an impressive selection of human cell lines, including cancer cells, RFP- and GFP-expressing cells, and more. Recently, a few publications were released that utilized cell lines purchased from Neuromics.
Weill Cornell Medical College investigators utilized SF-295 cells (cat. SF001), a human glioblastoma cell line, supplied by Neuromics in their cancer research. The scientists studied the evolution of genomic signatures in several tumor samples from urothelial cancer patients. The findings better define some of the mechanisms behind urothelial cancer evolution and give insights into therapeutic possibilities. Check out the paper here.
Image: DU 145 cells were incubated with diluted primary antibodies KRT18 and KRT19, then with fluorescent secondary antibodies (anti-mouse Cy2 and anti-rabbit Cy3) and mounted using iBright medium (SF40000).
Egyptian researchers published a study using WI-38 cells (cat. WI001), a human lung fibroblast cell line purchased from Neuromics, in diabetes research. They found that bee venom-loaded chitosan nanoparticles were a safe and effective treatment against diabetes in an in vivo rat model. According to the scientists, bee venom impacts pancreatic tissue through its antioxidants and anti-inflammatory properties. Read it here.
Lastly, time is running out on our 15% human cell sale - including all our cell lines. You can learn more here.